AKR1C

亜型選択性的な製品

AKR1C1 AKR1C2 AKR1C3 AKR1C4

AKR1C製品

All (4)
AKR1C阻害剤 (4)
新製品

製品コード	製品名称	製品説明	文献中Selleckの製品使用例	お客様のフィードバック
E8282^New	RJG-2051	RJG-2051 is a selective covalent SuTEx inhibitor of AKR1C3 with an IC50 of 13 nM that targets a noncatalytic tyrosine residue (Y24), effectively blocking its enzymatic activity and disrupting androgen, estrogen, and prostaglandin metabolism.
S0764	AKR1C1-IN-1	AKR1C1-IN-1 is a potent and selective inhibitor of human 20alpha-hydroxysteroid dehydrogenase (AKR1C1) with Ki of 4 nM, 87 nM, 4.2 μM and 18.2 μM for AKR1C1, AKR1C2, AKR1C3 and AKR1C4, respectively.
S3930	Liquiritin	Liquiritin (LIQ, Liquiritoside, Liquiritigenin-4'-O-glucoside) is a main component among the licorice flavonoids, and possesses anti-inflammatory and anti-cancer abilities.
S0468^New	AKR1C3-IN-1	AKR1C3-IN-1 is a highly potent inhibitor of aldo-keto reductaseAKR1C3 with an IC50 of 13 nM. It can be used in research targeting both breast and prostate cancer.
E8282^New	RJG-2051	RJG-2051 is a selective covalent SuTEx inhibitor of AKR1C3 with an IC50 of 13 nM that targets a noncatalytic tyrosine residue (Y24), effectively blocking its enzymatic activity and disrupting androgen, estrogen, and prostaglandin metabolism.
S0764	AKR1C1-IN-1	AKR1C1-IN-1 is a potent and selective inhibitor of human 20alpha-hydroxysteroid dehydrogenase (AKR1C1) with Ki of 4 nM, 87 nM, 4.2 μM and 18.2 μM for AKR1C1, AKR1C2, AKR1C3 and AKR1C4, respectively.
S3930	Liquiritin	Liquiritin (LIQ, Liquiritoside, Liquiritigenin-4'-O-glucoside) is a main component among the licorice flavonoids, and possesses anti-inflammatory and anti-cancer abilities.
S0468^New	AKR1C3-IN-1	AKR1C3-IN-1 is a highly potent inhibitor of aldo-keto reductaseAKR1C3 with an IC50 of 13 nM. It can be used in research targeting both breast and prostate cancer.
E8282^New	RJG-2051	RJG-2051 is a selective covalent SuTEx inhibitor of AKR1C3 with an IC50 of 13 nM that targets a noncatalytic tyrosine residue (Y24), effectively blocking its enzymatic activity and disrupting androgen, estrogen, and prostaglandin metabolism.
S0468^New	AKR1C3-IN-1	AKR1C3-IN-1 is a highly potent inhibitor of aldo-keto reductaseAKR1C3 with an IC50 of 13 nM. It can be used in research targeting both breast and prostate cancer.